Scientist Target Identification and Selection*
- You will be responsible for the identification and selection of novel tumor-specific HLA ligands to fuel Immatics’ internal and partnered target pipelines.
- You will utilize Immatics’ XPRESIDENT® target discovery platform to analyze a broad range of patient-individual as well as population-based Omics datasets (peptidomics, transcriptomics, genomics) and you will further research and include available relevant data into your selection process.
- You will join an interdisciplinary team of bioinformaticians, scientists and technology experts to develop new selection strategies. You will evaluate and support the integration of new technologies that will further optimize our target selection process.
- Ultimately you will identify the best immunotherapy targets for each tumor indication and patient with your scientific expertise, analytical thinking and passion to translate your research into clinical application.
This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.